HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James Abbruzzese Selected Research

James Abbruzzese Research Topics

Disease

17Neoplasms (Cancer)
01/2021 - 01/2001
12Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 11/2004
5Adenocarcinoma
01/2021 - 01/2001
3Colorectal Neoplasms (Colorectal Cancer)
01/2008 - 11/2002
2Inflammation (Inflammations)
01/2018 - 09/2010
2Neoplasm Metastasis (Metastasis)
12/2012 - 12/2007
1Brain Neoplasms (Brain Tumor)
01/2021
1Lung Neoplasms (Lung Cancer)
12/2009
1Pain (Aches)
12/2009
1Wound Infection (Wound Infections)
02/2009
1Anorexia
02/2009
1Proteinuria
02/2009
1Gastrointestinal Hemorrhage (Hematochezia)
02/2009
1Diarrhea
02/2009
1Hyperbilirubinemia
02/2009
1Hyperkalemia
02/2009
1Thrombocytopenia (Thrombopenia)
02/2009
1Back Pain (Backache)
02/2009
1Hypertension (High Blood Pressure)
02/2009
1Fatigue
02/2009
1Hepatocellular Carcinoma (Hepatoma)
02/2009
1Colonic Neoplasms (Colon Cancer)
01/2008
1Squamous Cell Neoplasms (Squamous Cell Cancer)
04/2004
1Carcinoma (Carcinomatosis)
11/2002
1Viremia
11/2002

Drug/Important Bio-Agent (IBA)

5GemcitabineFDA Link
03/2011 - 09/2003
5NF-kappa B (NF-kB)IBA
12/2009 - 11/2004
4CurcuminIBA
01/2018 - 11/2004
3Pharmaceutical PreparationsIBA
01/2018 - 02/2009
2Platelet-Derived Growth FactorIBA
01/2018 - 12/2007
2Biological ProductsIBA
04/2016 - 11/2004
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2010 - 12/2007
2InterleukinsIBA
09/2010 - 12/2009
2Interleukin-8 (Interleukin 8)IBA
12/2009 - 11/2004
2CytokinesIBA
12/2009 - 11/2002
2Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2009 - 11/2006
2GenisteinIBA
11/2006 - 10/2005
1Lapatinib (GW572016)FDA Link
01/2021
1Trastuzumab (Herceptin)FDA Link
01/2021
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Sp Transcription FactorsIBA
01/2018
1Metformin (Glucophage)FDA LinkGeneric
01/2018
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1MicellesIBA
06/2015
1cyclopamineIBA
06/2015
1Neoplasm Antigens (Tumor Antigens)IBA
04/2011
1VaccinesIBA
04/2011
1SurvivinIBA
04/2011
1ThioredoxinsIBA
03/2011
1Renilla LuciferasesIBA
09/2010
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
09/2010
1ChemokinesIBA
09/2010
1Interferon-betaIBA
09/2010
1bardoxolone methylIBA
09/2010
1Analgesics (Analgesic Drugs)IBA
12/2009
1DNA (Deoxyribonucleic Acid)IBA
12/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2009
1Interleukin-6 (Interleukin 6)IBA
12/2009
1Interleukin-10 (Interleukin 10)IBA
12/2009
1Interleukin-18 (Interleukin 18)IBA
12/2009
1Transaminases (Aminotransferases)IBA
02/2009
1Bevacizumab (Avastin)FDA Link
02/2009
1Protein Glutamine gamma Glutamyltransferase 2IBA
04/2008
1Focal Adhesion Protein-Tyrosine KinasesIBA
04/2008
1PTEN Phosphohydrolase (PTEN Phosphatase)IBA
04/2008
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2008
1Fluorouracil (Carac)FDA LinkGeneric
01/2008
1Irinotecan (Camptosar)FDA LinkGeneric
01/2008
1Small Interfering RNA (siRNA)IBA
12/2007
1Complementary DNA (cDNA)IBA
12/2007
1Matrix Metalloproteinases (MMPs)IBA
12/2007
1ErbB Receptors (EGF Receptor)IBA
11/2006
1Antineoplastic Agents (Antineoplastics)IBA
10/2005
1IsoflavonesIBA
10/2005
1I-kappa B KinaseIBA
11/2004
1EnzymesIBA
11/2004
1Transcription Factors (Transcription Factor)IBA
11/2004
1Dinoprostone (PGE2)FDA Link
11/2004
1PhytochemicalsIBA
11/2004
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2004
1Blood Proteins (Serum Proteins)IBA
01/2004
1irofulvenIBA
04/2003
1dl1520 (ONYX-015)IBA
11/2002
1Neutralizing AntibodiesIBA
11/2002
1Antiviral Agents (Antivirals)IBA
11/2002
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2001

Therapy/Procedure

8Therapeutics
01/2021 - 01/2001
4Drug Therapy (Chemotherapy)
01/2021 - 11/2002
2Neoadjuvant Therapy
12/2012 - 01/2012
2Aftercare (After-Treatment)
09/2010 - 11/2002
1Immunotherapy
01/2021
1Radiotherapy
06/2015
1Pancreatectomy
12/2012
1Pancreaticoduodenectomy
01/2012
1Injections
09/2010
1Analgesia
12/2009
1Colostomy
04/2004
1Combined Modality Therapy
04/2004